Global At-Home Drug of Abuse (DOA) Testing Market Size, Status and Forecast 2024-2031

Report ID: 1012525 | Published Date: Jan 2025 | No. of Page: 98 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Test Cups
        1.2.3 Test Dip Cards
        1.2.4 Test Strips
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global At-Home Drug of Abuse (DOA) Testing Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Urine
        1.3.3 Saliva
        1.3.4 Hair
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global At-Home Drug of Abuse (DOA) Testing Market Perspective (2016-2027)
    2.2 At-Home Drug of Abuse (DOA) Testing Growth Trends by Regions
        2.2.1 At-Home Drug of Abuse (DOA) Testing Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 At-Home Drug of Abuse (DOA) Testing Historic Market Share by Regions (2016-2021)
        2.2.3 At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Regions (2022-2027)
    2.3 At-Home Drug of Abuse (DOA) Testing Industry Dynamic
        2.3.1 At-Home Drug of Abuse (DOA) Testing Market Trends
        2.3.2 At-Home Drug of Abuse (DOA) Testing Market Drivers
        2.3.3 At-Home Drug of Abuse (DOA) Testing Market Challenges
        2.3.4 At-Home Drug of Abuse (DOA) Testing Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top At-Home Drug of Abuse (DOA) Testing Players by Revenue
        3.1.1 Global Top At-Home Drug of Abuse (DOA) Testing Players by Revenue (2016-2021)
        3.1.2 Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Players (2016-2021)
    3.2 Global At-Home Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by At-Home Drug of Abuse (DOA) Testing Revenue
    3.4 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio
        3.4.1 Global At-Home Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by At-Home Drug of Abuse (DOA) Testing Revenue in 2020
    3.5 At-Home Drug of Abuse (DOA) Testing Key Players Head office and Area Served
    3.6 Key Players At-Home Drug of Abuse (DOA) Testing Product Solution and Service
    3.7 Date of Enter into At-Home Drug of Abuse (DOA) Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 At-Home Drug of Abuse (DOA) Testing Breakdown Data by Type
    4.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Type (2016-2021)
    4.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2022-2027)

5 At-Home Drug of Abuse (DOA) Testing Breakdown Data by Application
    5.1 Global At-Home Drug of Abuse (DOA) Testing Historic Market Size by Application (2016-2021)
    5.2 Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America At-Home Drug of Abuse (DOA) Testing Market Size (2016-2027)
    6.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type
        6.2.1 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2021)
        6.2.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2022-2027)
        6.2.3 North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2027)
    6.3 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application
        6.3.1 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2021)
        6.3.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2022-2027)
        6.3.3 North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2027)
    6.4 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country
        6.4.1 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2016-2021)
        6.4.2 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size (2016-2027)
    7.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type
        7.2.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2021)
        7.2.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2022-2027)
        7.2.3 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2027)
    7.3 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application
        7.3.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2021)
        7.3.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2022-2027)
        7.3.3 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2027)
    7.4 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country
        7.4.1 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2016-2021)
        7.4.2 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size (2016-2027)
    8.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type
        8.2.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2027)
    8.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application
        8.3.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2027)
    8.4 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region
        8.4.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size (2016-2027)
    9.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type
        9.2.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2021)
        9.2.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2022-2027)
        9.2.3 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2027)
    9.3 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application
        9.3.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2021)
        9.3.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2022-2027)
        9.3.3 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2027)
    9.4 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country
        9.4.1 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2016-2021)
        9.4.2 Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size (2016-2027)
    10.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type
        10.2.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2027)
    10.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application
        10.3.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2027)
    10.4 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country
        10.4.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 UCP Biosciences
        11.1.1 UCP Biosciences Company Details
        11.1.2 UCP Biosciences Business Overview
        11.1.3 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Introduction
        11.1.4 UCP Biosciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
        11.1.5 UCP Biosciences Recent Development
    11.2 Orient New Life Medical
        11.2.1 Orient New Life Medical Company Details
        11.2.2 Orient New Life Medical Business Overview
        11.2.3 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Introduction
        11.2.4 Orient New Life Medical Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
        11.2.5 Orient New Life Medical Recent Development
    11.3 Express Diagnostics Int’l
        11.3.1 Express Diagnostics Int’l Company Details
        11.3.2 Express Diagnostics Int’l Business Overview
        11.3.3 Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Introduction
        11.3.4 Express Diagnostics Int’l Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
        11.3.5 Express Diagnostics Int’l Recent Development
    11.4 Assure Tech (Hangzhou)
        11.4.1 Assure Tech (Hangzhou) Company Details
        11.4.2 Assure Tech (Hangzhou) Business Overview
        11.4.3 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Introduction
        11.4.4 Assure Tech (Hangzhou) Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
        11.4.5 Assure Tech (Hangzhou) Recent Development
    11.5 Psychemedics Corporation
        11.5.1 Psychemedics Corporation Company Details
        11.5.2 Psychemedics Corporation Business Overview
        11.5.3 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Introduction
        11.5.4 Psychemedics Corporation Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
        11.5.5 Psychemedics Corporation Recent Development
    11.6 Confirm BioSciences
        11.6.1 Confirm BioSciences Company Details
        11.6.2 Confirm BioSciences Business Overview
        11.6.3 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Introduction
        11.6.4 Confirm BioSciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
        11.6.5 Confirm BioSciences Recent Development
    11.7 Phamatech
        11.7.1 Phamatech Company Details
        11.7.2 Phamatech Business Overview
        11.7.3 Phamatech At-Home Drug of Abuse (DOA) Testing Introduction
        11.7.4 Phamatech Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
        11.7.5 Phamatech Recent Development
    11.8 Home Health (U.K.) Ltd.
        11.8.1 Home Health (U.K.) Ltd. Company Details
        11.8.2 Home Health (U.K.) Ltd. Business Overview
        11.8.3 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Introduction
        11.8.4 Home Health (U.K.) Ltd. Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
        11.8.5 Home Health (U.K.) Ltd. Recent Development
    11.9 Quest Products
        11.9.1 Quest Products Company Details
        11.9.2 Quest Products Business Overview
        11.9.3 Quest Products At-Home Drug of Abuse (DOA) Testing Introduction
        11.9.4 Quest Products Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
        11.9.5 Quest Products Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global At-Home Drug of Abuse (DOA) Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Test Cups
    Table 3. Key Players of Test Dip Cards
    Table 4. Key Players of Test Strips
    Table 5. Key Players of Others
    Table 6. Global At-Home Drug of Abuse (DOA) Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global At-Home Drug of Abuse (DOA) Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global At-Home Drug of Abuse (DOA) Testing Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global At-Home Drug of Abuse (DOA) Testing Market Share by Regions (2016-2021)
    Table 10. Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global At-Home Drug of Abuse (DOA) Testing Market Share by Regions (2022-2027)
    Table 12. At-Home Drug of Abuse (DOA) Testing Market Trends
    Table 13. At-Home Drug of Abuse (DOA) Testing Market Drivers
    Table 14. At-Home Drug of Abuse (DOA) Testing Market Challenges
    Table 15. At-Home Drug of Abuse (DOA) Testing Market Restraints
    Table 16. Global At-Home Drug of Abuse (DOA) Testing Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global At-Home Drug of Abuse (DOA) Testing Market Share by Players (2016-2021)
    Table 18. Global Top At-Home Drug of Abuse (DOA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in At-Home Drug of Abuse (DOA) Testing as of 2020)
    Table 19. Ranking of Global Top At-Home Drug of Abuse (DOA) Testing Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by At-Home Drug of Abuse (DOA) Testing Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players At-Home Drug of Abuse (DOA) Testing Product Solution and Service
    Table 23. Date of Enter into At-Home Drug of Abuse (DOA) Testing Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Type (2016-2021)
    Table 27. Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global At-Home Drug of Abuse (DOA) Testing Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Application (2016-2021)
    Table 31. Global At-Home Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America At-Home Drug of Abuse (DOA) Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. UCP Biosciences Company Details
    Table 64. UCP Biosciences Business Overview
    Table 65. UCP Biosciences At-Home Drug of Abuse (DOA) Testing Product
    Table 66. UCP Biosciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021) & (US$ Million)
    Table 67. UCP Biosciences Recent Development
    Table 68. Orient New Life Medical Company Details
    Table 69. Orient New Life Medical Business Overview
    Table 70. Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Product
    Table 71. Orient New Life Medical Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021) & (US$ Million)
    Table 72. Orient New Life Medical Recent Development
    Table 73. Express Diagnostics Int’l Company Details
    Table 74. Express Diagnostics Int’l Business Overview
    Table 75. Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Product
    Table 76. Express Diagnostics Int’l Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021) & (US$ Million)
    Table 77. Express Diagnostics Int’l Recent Development
    Table 78. Assure Tech (Hangzhou) Company Details
    Table 79. Assure Tech (Hangzhou) Business Overview
    Table 80. Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Product
    Table 81. Assure Tech (Hangzhou) Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021) & (US$ Million)
    Table 82. Assure Tech (Hangzhou) Recent Development
    Table 83. Psychemedics Corporation Company Details
    Table 84. Psychemedics Corporation Business Overview
    Table 85. Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Product
    Table 86. Psychemedics Corporation Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021) & (US$ Million)
    Table 87. Psychemedics Corporation Recent Development
    Table 88. Confirm BioSciences Company Details
    Table 89. Confirm BioSciences Business Overview
    Table 90. Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Product
    Table 91. Confirm BioSciences Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021) & (US$ Million)
    Table 92. Confirm BioSciences Recent Development
    Table 93. Phamatech Company Details
    Table 94. Phamatech Business Overview
    Table 95. Phamatech At-Home Drug of Abuse (DOA) Testing Product
    Table 96. Phamatech Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021) & (US$ Million)
    Table 97. Phamatech Recent Development
    Table 98. Home Health (U.K.) Ltd. Company Details
    Table 99. Home Health (U.K.) Ltd. Business Overview
    Table 100. Home Health (U.K.) Ltd. Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021) & (US$ Million)
    Table 101. Home Health (U.K.) Ltd. Recent Development
    Table 102. Quest Products Company Details
    Table 103. Quest Products Business Overview
    Table 104. Quest Products At-Home Drug of Abuse (DOA) Testing Product
    Table 105. Quest Products Revenue in At-Home Drug of Abuse (DOA) Testing Business (2016-2021) & (US$ Million)
    Table 106. Quest Products Recent Development
    Table 107. Research Programs/Design for This Report
    Table 108. Key Data Information from Secondary Sources
    Table 109. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global At-Home Drug of Abuse (DOA) Testing Market Share by Type: 2020 VS 2027
    Figure 2. Test Cups Features
    Figure 3. Test Dip Cards Features
    Figure 4. Test Strips Features
    Figure 5. Others Features
    Figure 6. Global At-Home Drug of Abuse (DOA) Testing Market Share by Application: 2020 VS 2027
    Figure 7. Urine Case Studies
    Figure 8. Saliva Case Studies
    Figure 9. Hair Case Studies
    Figure 10. Others Case Studies
    Figure 11. At-Home Drug of Abuse (DOA) Testing Report Years Considered
    Figure 12. Global At-Home Drug of Abuse (DOA) Testing Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global At-Home Drug of Abuse (DOA) Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global At-Home Drug of Abuse (DOA) Testing Market Share by Regions: 2020 VS 2027
    Figure 15. Global At-Home Drug of Abuse (DOA) Testing Market Share by Regions (2022-2027)
    Figure 16. Global At-Home Drug of Abuse (DOA) Testing Market Share by Players in 2020
    Figure 17. Global Top At-Home Drug of Abuse (DOA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in At-Home Drug of Abuse (DOA) Testing as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by At-Home Drug of Abuse (DOA) Testing Revenue in 2020
    Figure 19. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Type (2016-2021)
    Figure 20. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Type (2022-2027)
    Figure 21. North America At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America At-Home Drug of Abuse (DOA) Testing Market Share by Type (2016-2027)
    Figure 23. North America At-Home Drug of Abuse (DOA) Testing Market Share by Application (2016-2027)
    Figure 24. North America At-Home Drug of Abuse (DOA) Testing Market Share by Country (2016-2027)
    Figure 25. United States At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe At-Home Drug of Abuse (DOA) Testing Market Share by Type (2016-2027)
    Figure 29. Europe At-Home Drug of Abuse (DOA) Testing Market Share by Application (2016-2027)
    Figure 30. Europe At-Home Drug of Abuse (DOA) Testing Market Share by Country (2016-2027)
    Figure 31. Germany At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Share by Region (2016-2027)
    Figure 41. China At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America At-Home Drug of Abuse (DOA) Testing Market Share by Type (2016-2027)
    Figure 49. Latin America At-Home Drug of Abuse (DOA) Testing Market Share by Application (2016-2027)
    Figure 50. Latin America At-Home Drug of Abuse (DOA) Testing Market Share by Country (2016-2027)
    Figure 51. Mexico At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Share by Country (2016-2027)
    Figure 57. Turkey At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE At-Home Drug of Abuse (DOA) Testing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. UCP Biosciences Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
    Figure 61. Orient New Life Medical Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
    Figure 62. Express Diagnostics Int’l Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
    Figure 63. Assure Tech (Hangzhou) Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
    Figure 64. Psychemedics Corporation Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
    Figure 65. Confirm BioSciences Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
    Figure 66. Phamatech Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
    Figure 67. Home Health (U.K.) Ltd. Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
    Figure 68. Quest Products Revenue Growth Rate in At-Home Drug of Abuse (DOA) Testing Business (2016-2021)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
UCP Biosciences
Orient New Life Medical
Express Diagnostics Int’l
Assure Tech (Hangzhou)
Psychemedics Corporation
Confirm BioSciences
Phamatech
Home Health (U.K.) Ltd.
Quest Products
Frequently Asked Questions
At-Home Drug of Abuse (DOA) Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
At-Home Drug of Abuse (DOA) Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
At-Home Drug of Abuse (DOA) Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Connected Industries

Connected industries is a new concept framework, which means that industries will create new adde ... Read More

Sol-Gel Processing

The sol–gel process is a method for producing solid materials from small molecules. The method  ... Read More